Treatment of hypertensive patients in community pharmacies in Yogyakarta
Hypertension is one of the degenerative diseases that has quite high mortality and morbidity. Rational drug management in hypertensive patients has become an increasingly important topic to make optimal use of the treatment to provide the highest possible standard of health care. Continuous assessment of rational drug prescription and use should be carried out in patients. The purpose of this study is to identify the trend of drug prescription and using antihypertensive groups in hypertensive patients in community pharmacies in Yogyakarta in 2024. This study aimed to conduct a retrospective cross-sectional study of prescription patterns in hypertensive patients in the community. The review of drug prescription characteristics includes gender, age, comorbidities, duration of treatment, and number of drugs used. The results showed that 56.06% of hypertensive patients were male patients, the dominant age in this study was over 60 years (59.09%). The duration of treatment in this study was dominated by 5-10 days (79.55%). Hypertensive patients usually have 1-3 comorbidities so that be will affect the treatment received. As many as 84.85% of hypertensive patients use a single hypertension drug. Amlodipine is a CCB group that is the first line of hypertension treatment in the community. The combination of treatments that often used is a combination of the CCB group (amlodipine) with the diuretic group (furosemide).
Authors
- Heni Lutfiyati (ORCID: https://orcid.org/0000-0003-4423-256X)
- Nurfina Dian Kartikawati (ORCID: https://orcid.org/0000-0003-3554-8036)
- Megananda Hiranya Putri (ORCID: https://orcid.org/0000-0001-8608-7028)
- Dwi Hastuti
- Fitriana Yuliastuti (ORCID: https://orcid.org/0009-0007-8605-1595)
- Nir Amir
- Putri Sumiati
Institutions
- Universitas Muhammadiyah Magelang (ID)
- Universitas Teknologi Yogyakarta (ID)
- Institut Seni Indonesia Yogyakarta (ID)
Publication Details
- Journal
- BIS Health and Environmental Science
- Published
- 2025-05-26
- DOI
- https://doi.org/10.31603/bishes.252
- Primary Topic
- Pharmaceutical Practices and Patient Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00